Invitrogen™ Peptide synthétique DR6 humain
DR6 Synthetic Peptide, PEP-0055, from Invitrogen.
- Gene ID (Entrez)
- 27242
- Espèces
- Human
- Méthode de purification
- purified
- Numéro d’adhésion
- O75509
- Nom usuel
- Human DR6
- Marque
- Invitrogen
DR6 Synthetic Peptide, PEP-0055, from Invitrogen.
DR6 Synthetic Peptide, PEP-0055, from Invitrogen.
DR6 is widely expressed in human tissues and cell lines. The ligand for DR6 has not been identified. Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domain containing receptors, TNF-R1 and Fas. Several novel death receptors including DR3, DR4, and DR5 were recently identified. A new death domain containing receptor in the TNFR family was cloned recently and termed DR6 for death receptor-6. Like TNF-R1, DR6 interacts with death domain containing adapter molecule TRADD. Overexpression of DR6 induces apoptosis and activates NF-kappa-B and JNK.
Espèces : Humaine.
Conservation : -20°C.
Concentration : 200 μg/mL.
Réservé à la recherche (RUO).
Conditionnement : 50 μg.
| Général | |
|---|---|
| Marque | Invitrogen |
| Réf. fournisseur (Fisher Scientific) | 15286279 |
| Caractéristiques | |
| Gene ID (Entrez) | 27242 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | O75509 |
| Nom usuel | Human DR6 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | TNFRSF21 |
| Lyophilisé | No |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Stockage et expédition | |
| Contenu et stockage | -20°C |
| Conservateur | 0.02% sodium azide |
| Tampon de stockage | PBS |
| Réf. fabricant | PEP-0055 |
|---|---|
| Pays d’origine | États-Unis |
| Code douanier (SH) | 3824 99 96 00 |